Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Allakos Inc
(NQ:
ALLK
)
0.6820
+0.0220 (+3.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Allakos Inc
< Previous
1
2
3
4
5
Next >
32 Stocks Moving In Wednesday's Mid-Day Session
December 22, 2021
Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 31.7% to $2.41 after the company announced it was awarded a multiple award blanket purchase agreement by the United...
Via
Benzinga
Expert Ratings For Allakos
December 22, 2021
Allakos (NASDAQ:ALLK) has observed the following analyst ratings within the...
Via
Benzinga
Mid-Morning Market Update: Markets Edge Higher; CarMax Profit Tops Estimates
December 22, 2021
Following the market opening Wednesday, the Dow traded up 0.11% to 35,530.68 while the NASDAQ rose 0.02% to 15,344.33. The S&P also rose, gaining 0.13% to 4,655.40. The U.S....
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021
December 22, 2021
Upgrades According to Loop Capital, the prior rating for Williams-Sonoma Inc (NYSE:
Via
Benzinga
Allakos' Shares Nosedive After Lirentelimab Studies Fail To Achieve Statistical Significance On Symptomatic Endpoints
December 22, 2021
Allakos Inc (NASDAQ: ALLK) reported data from ENIGMA 2 Phase 3 study of lirentelimab in eosinophilic gastritis (EG) or eosinophilic duodenitis (EoD) and KRYPTOS Phase 2/3...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 22, 2021
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 54.72% to $2.29 during Wednesday's pre-market session. The company's market cap stands at $...
Via
Benzinga
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
December 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Allakos's Lirentelimab Flunks Late-Stage Studies In Patients With...
Via
Benzinga
3 Biotech Stocks With Huge Catalysts Incoming
October 22, 2021
These drugmakers have big events that should occur before the end of 2021.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021
August 26, 2021
Upgrades Scotiabank upgraded the previous rating for Enerplus Corp (NYSE:
Via
Benzinga
3 Biotech Stocks That Could Double Soon
July 21, 2021
Wall Street analysts following these drugmakers think they can produce big gains in a short time frame.
Via
The Motley Fool
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021
May 18, 2021
Upgrades Janney Montgomery Scott upgraded the previous rating for Centerspace (NYSE:CSR) from Neutral to Buy. In the first quarter, Centerspace showed an EPS of $0.95,...
Via
Benzinga
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex
April 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.